Peripheral neuropathy is a common side effect of chemotherapy.
Those who have peripheral neuropathy may experience weakness, numbness, tingling sensations and pain in their hands and feet.
The Chemotherapy Induced Peripheral Neuropathy (CIPN) clinical trial aims to find which self-managed treatments (heat or massage) reduce the symptoms of peripheral neuropathy.
QUT, in collaboration with our research partners and Queensland Health, is working hard to assist cancer patients to maintain a high-level quality of life after treatment.
The Chemotherapy Induced Peripheral Neuropathy (CIPN) clinical trial aims to improve the quality of
life of those who are living with the pain and symptoms of peripheral neuropathy as a direct result of chemotherapy.
Please note: Recruitment for this trial has now closed.
This trial has been approved by the QUT Research Ethics Office. Our researchers follow the QUT Code of Conduct for Research.